S I:\CE 19.62, app~o~imately 1 million to 2.2 million ha\'e been reported in abstrac~ ~orm..-1 On April 16, \\'omen in the Lnlted States and Canada ha\.e re-1992, the Food and Drug Administration banned furcei\'ed silicone breast implants as part of reconstructher use of these de\.ices, except for limited use in retion follo\\"ing surgery for breast cancer or proph~'lactic search settings.1 mastectom~' or for cosmetic reasons.I.:! Silicone breast 'To stud~' the relation bet\\"een silicone breast imimplants have been linked to a variet~. of illnesses, the plants and connecti\'e-tissue diseases, we anal~.zed data most controversial of \\'hich are connective-tissue disfrom 1.1, years of follo\v-up of the ~urses' Health Stud~. eases and s~.mptoms.I.J Since 1982, at least 293 pacohort with respect to connective-tissue diseases that tients \\'ith connective-tissue diseases or rheumatic were diagnosed before June 1, 1990. \l\iïdespread media illnesses and silicone breast implants have been decoverage in the l"nited States of a possible association scribed in the English literature; many additional cases began in December 1990, after a program on the subject was aired on national tele\'ision.i In future cases involving rheumatic diseases possibly associated with an enviro"m~t~J agent, we cali upon the FDA and other regulAtory agencies ta allow professional socieries, sucll as the American College ofRheuma:tology, to foster appropriate and scientifically developed cpidemiological studies. Anecdotal reports, while of importance to call attention ta a poteDrial problem, should not be utilized ta fOInlulate decisions and re gu1ati 0 ns .
The American College ofRheumatology is the professional org~n;'7~tion of rheumatologiStS. It includes practicing physicians, research scientists, and health professionals who are dedicatedta h~ing, prevcD:ting disability, and eventUally curing the more than 100 types of arthritis and rc1a.ted disabling and sometimes fatal disorders of the joints, muscles, and bones. were included in our meta-analyses. We conducted a meta-analysis that dealt with unadjusted estimates ; m.eta-analy.ses of t~e results of these stl!dies, bath of effect but did not consider the effect of adjustment wlth and wlthout adjus!ment f?r confoundl':1g facto~~, for potential cortfounding factors.Wong8 and Hochand a sep~rate analY~ls restrlcte.d to studles .of slllberg and PerlInutter9performed analyses of adjusted cone-gel-filled breast Implants. Flnally, we ~stln:'ated effects but in neither srody were format statistical the annual number of new cases of connectlve-tlssue f ' . . disease that cou Id be attributed ta breast implants.
tests 0 hom~genelty ~ong srodie~ ~~ertaken, ~or Results There was no evidence that breast imwere an~ys~s of the rn~uence of rndivldual srodies plants were associated with a significant increase in or combrnatlons ofsrodiesco~ducted. N?~e ofthese thesummary adjusted relative risk of individual conmeta-analyses focused excluslvely on sillcone-gel- nd Sjogren s syndro":,e, 1.42 ~9~ percent c~nfld.ence We conducted a comprehensive series of metaI~terval, 0.65 t~ 3.11]), ail deflnlte connec~lve-tlss.ue analyses of the largest group ofsrodies to date to indlseases comblned (0.80; 95 percent confidence In-.. . . . terval, 0.62 ta 1.04); or other autoimmune or rheu.
~estIgate the posslb~e relatIon ?etween silico~~ breast matic conditions (0.96; 95 percent confidence interval, Implant~ an? the ~lsk ofautolmm~e conditions or 0.74 ta 1.25). Nor was there evidence of significantly connectIve-tIssue diseases. Oursrody mcorporated the increased risk in the unadjusted analyses or in the eightsrodies not included in the earlier meta-analyanalysis restricted ta silicone-gel-filled implants.
ses and had four principal objectives; ta investigate Conclusions On the basis of our meta-analyses, the relation between breast implants and connectivethere was no evidence of an association between tissue diseases by incorporating all eligible srodies intõ reast implant~ ~n general, or silicone-~el-:fi!led breast an unadjusted analysis; to consider the effect of poImpl.ants. speclfl.cally, and any.o! the Indlvl~ual. contential cortfounding factors in an adjusted analysis; n.ectlve-tlssue ~Iseases, ail deflnlte ?Onnectlve-tlssue to search for sources of heterogeneity among the dlseases comblned, or other autolmmune or rheu. 
